Lucie Wolf

Lucie Wolf

Auto-generated profile, based on publicly available information

Lucie Wolf

Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Developmental Cell
Verified
Journal Article
Closed access
CDChristina L. Dix
Christina L. Dix
HMHelen K. Matthews
Helen K. Matthews
MUMarina Uroz
Marina Uroz
SMSusannah McLaren
Susannah McLaren
LWLucie Wolf
Lucie Wolf
BBBuzz Baum
Buzz Baum

15 October 2015 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
FCFrédéric Chevessier
Frédéric Chevessier
JSJulia Schuld
Julia Schuld
ZOZacharias Orfanos
Zacharias Orfanos
APAnne-C. Plank
Anne-C. Plank
LWLucie Wolf
Lucie Wolf
RSRolf Schröder
Rolf Schröder
Filamin C (FLNC) mutations in humans cause myofibrillar myopathy (MFM) and cardiomyopathy, characterized by protein aggregation and myofibrillar degeneration. We generated the first patient-mimicking knock-in mouse harbouring the most common disease-causing filamin C mutation (p.W2710X). These heterozygous mice developed muscle weakness and myofibrillar instability, with formation of filamin C- and Xin-positive lesions streaming between Z-discs. These lesions, which are distinct from the classical MFM protein aggregates by their morphology and filamentous appearance, were greatly increased in number upon acute physical exercise in the mice. This pathology suggests that mutant filamin influences the mechanical stability of myofibrillar Z-discs, explaining the muscle weakness in mice and humans. Re-evaluation of biopsies from MFM-filaminopathy patients with different FLNC mutations revealed a similar, previously unreported lesion pathology, in addition to the classical protein aggregates, and suggested that structures previously interpreted as aggregates may be in part sarcomeric lesions. We postulate that these lesions define preclinical disease stages, preceding the formation of protein aggregates.

15 July 2017 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
SBStéphanie Bauché
Stéphanie Bauché
GVGeoffroy Vellieux
Geoffroy Vellieux
DSDamien Sternberg
Damien Sternberg
MFMarie-Joséphine Fontenille
Marie-Joséphine Fontenille
EBElodie De Bruyckere
Elodie De Bruyckere
SNSophie Nicole
Sophie Nicole

15 August 2021 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
LWLucie M. Wolf
Lucie M. Wolf
ALAnnika M. Lambert
Annika M. Lambert
JHJulie Haenlin
Julie Haenlin
MBMichael Boutros
Michael Boutros
WNT signalling is important for development in all metazoans and is associated with various human diseases. The ubiquitin–proteasome system (UPS) and regulatory endoplasmic reticulum-associated degradation (ERAD) have been implicated in the production of WNT proteins. Here, we investigated how the WNT secretory factor EVI (also known as WLS) is ubiquitylated, recognised by ERAD components and subsequently removed from the secretory pathway. We performed a focused immunoblot-based RNAi screen for factors that influence EVI/WLS protein stability. We identified the VCP-binding proteins FAF2 and UBXN4 as novel interaction partners of EVI/WLS and showed that ERLIN2 links EVI/WLS to the ubiquitylation machinery. Interestingly, we also found that EVI/WLS is ubiquitylated and degraded in cells irrespective of their level of WNT production. This K11, K48 and K63-linked ubiquitylation is mediated by the E2 ubiquitin-conjugating enzymes UBE2J2, UBE2K and UBE2N, but is independent of the E3 ubiquitin ligases HRD1 (also known as SYVN1) and GP78 (also known as AMFR). Taken together, our study identifies factors that link the UPS to the WNT secretory pathway and provides mechanistic details of the fate of an endogenous substrate of regulatory ERAD in mammalian cells. This article has an associated First Person interview with the first author of the paper.

10 February 2023 in Development
Verified
Journal Article
Open access
PDF file
LWLucie Wolf
Lucie Wolf
MBMichael Boutros
Michael Boutros
Intercellular communication by Wnt proteins governs many essential processes during development, tissue homeostasis and disease in all metazoans. Many context-dependent effects are initiated in the Wnt-producing cells and depend on the export of lipidated Wnt proteins. Although much focus has been on understanding intracellular Wnt signal transduction, the cellular machinery responsible for Wnt secretion became better understood only recently. After lipid modification by the acyl-transferase Porcupine, Wnt proteins bind their dedicated cargo protein Evi/Wntless for transport and secretion. Evi/Wntless and Porcupine are conserved transmembrane proteins, and their 3D structures were recently determined. In this Review, we summarise studies and structural data highlighting how Wnts are transported from the ER to the plasma membrane, and the role of SNX3-retromer during the recycling of its cargo receptor Evi/Wntless. We also describe the regulation of Wnt export through a post-translational mechanism and review the importance of Wnt secretion for organ development and cancer, and as a future biomarker.

21 December 2023 in Cancer Research Communications
Verified
Journal Article
Open access
PDF file
SOSiobhan O'BRien
Siobhan O'BRien
TUTajinder Ubhi
Tajinder Ubhi
LWLucie Wolf
Lucie Wolf
KGKrishna Gandhi
Krishna Gandhi
SLSichun Lin
Sichun Lin
SAStephane Angers
Stephane Angers
FBXW7 is a commonly mutated tumor suppressor gene that functions to regulate numerous oncogenes involved in cell-cycle regulation. Genome-wide CRISPR fitness screens identified a signature of DNA repair and DNA damage response genes as required for the growth of FBXW7-knockout cells. Guided by these findings, we show that FBXW7-mutant cells have high levels of replication stress, which results in a genotype-specific vulnerability to inhibition of the ATR signaling pathway, as these mutant cells become heavily reliant on a robust S–G2 checkpoint. ATR inhibition induces an accelerated S-phase, leading to mitotic catastrophe and cell death caused by the high replication stress present in FBXW7−/− cells. In addition, we provide evidence in cell and organoid studies, and mining of publicly available high-throughput drug screening efforts, that this genotype-specific vulnerability extends to multiple types of cancer, providing a rational means of identifying responsive patients for targeted therapy. Significance: We have elucidated the synthetic lethal interactions between FBXW7 mutation and DNA damage response genes, and highlighted the potential of ATR inhibitors as targeted therapies for cancers harboring FBXW7 alterations.